1. Zhang, Huhu, Dong, Xiaolei, Ding, Xiaoyan, Li, Bing, Yang, Lina. 2023. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. In Journal of translational medicine, 21, 900. doi:10.1186/s12967-023-04613-6. https://pubmed.ncbi.nlm.nih.gov/38082327/
2. Pulliam, Thomas L, Goli, Pavithr, Awad, Dominik, Wilkenfeld, Sandi R, Frigo, Daniel E. 2022. Regulation and role of CAMKK2 in prostate cancer. In Nature reviews. Urology, 19, 367-380. doi:10.1038/s41585-022-00588-z. https://pubmed.ncbi.nlm.nih.gov/35474107/
3. Xiang, Honggang, Zhang, Jifa, Lin, Congcong, Liu, Bo, Ouyang, Liang. 2019. Targeting autophagy-related protein kinases for potential therapeutic purpose. In Acta pharmaceutica Sinica. B, 10, 569-581. doi:10.1016/j.apsb.2019.10.003. https://pubmed.ncbi.nlm.nih.gov/32322463/
4. Jin, Lingtao, Chun, Jaemoo, Pan, Chaoyun, Owonikoko, Taofeek K, Kang, Sumin. 2017. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. In Molecular cell, 69, 87-99.e7. doi:10.1016/j.molcel.2017.11.025. https://pubmed.ncbi.nlm.nih.gov/29249655/
5. Wu, Yulun, Jia, Chaoran, Liu, Wei, Sun, Luguo, Song, Zhenbo. 2024. Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer. In Journal of advanced research, 65, 89-104. doi:10.1016/j.jare.2024.04.033. https://pubmed.ncbi.nlm.nih.gov/38724006/
智鼠故事 
